Omnaris Generic Name & Formulations
Legal Class
Rx
General Description
Ciclesonide 50mcg/spray; aqueous nasal spray.
Pharmacological Class
Steroid.
How Supplied
Nasal spray (pump)—12.5g (120 sprays)
Manufacturer
Omnaris Indications
Indications
Treatment of seasonal allergic rhinitis in patients ≥6yrs old and perennial allergic rhinitis in patients ≥12yrs old.
Omnaris Dosage and Administration
Adult
2 sprays in each nostril once daily (200mcg/day).
Children
Seasonal allergic rhinitis: <6yrs: not recommended. ≥6yrs: 2 sprays in each nostril once daily (200mcg/day).
Omnaris Contraindications
Not Applicable
Omnaris Boxed Warnings
Not Applicable
Omnaris Warnings/Precautions
Warnings/Precautions
Avoid use in patients with recent nasal ulcers/surgery/trauma until healed. Potential worsening of active tuberculosis; fungal, bacterial, viral, or parasitic infections, or ocular herpes simplex. If exposed to measles or chickenpox, consider immunoglobulin prophylactic therapy. If adrenal suppression exists following systemic corticosteroid therapy, replacement with topical steroids may exacerbate symptoms of adrenal insufficiency. Monitor for hypercorticism and HPA axis suppression (if occur discontinue slowly), and for candida infection and other nasal mucosal changes. Monitor for vision changes or with history of increased intraocular pressure, glaucoma and/or cataracts. Monitor for growth suppression in children. Avoid spraying eyes, or directly onto the nasal septum. Reevaluate if no improvement after 2 weeks (for seasonal allergic rhinitis) and 5 weeks (for perennial allergic rhinitis). Pregnancy. Nursing mothers.
Omnaris Pharmacokinetics
See Literature
Omnaris Interactions
Interactions
May be potentiated by ketoconazole.
Omnaris Adverse Reactions
Adverse Reactions
Headache, epistaxis, nasopharyngitis, ear pain, pharyngolaryngeal pain.
Omnaris Clinical Trials
See Literature
Omnaris Note
Not Applicable
Omnaris Patient Counseling
See Literature
Images
